An Overview of Macrolide Resistance in Streptococci: Prevalence, Mobile Elements and Dynamics

Overview

Journal Microorganisms

Specialty Microbiology

Date 2022 Dec 23

PMID 36557569

Authors

Damaris Berbel

Aida Gonzalez-Diaz

Guillem Lopez de Egea

Jordi Camara

Carmen Ardanuy

Affiliations

Soon will be listed here.

Abstract

Streptococcal infections are usually treated with beta-lactam antibiotics, but, in case of allergic patients or reduced antibiotic susceptibility, macrolides and fluoroquinolones are the main alternatives. This work focuses on studying macrolide resistance rates, genetic associated determinants and antibiotic consumption data in Spain, Europe and also on a global scale. Macrolide resistance (MR) determinants, such as ribosomal methylases ((B), (TR), (T)) or active antibiotic efflux pumps and ribosomal protectors ((A/E)-(D)), are differently distributed worldwide and associated with different clonal lineages and mobile genetic elements. MR rates vary together depending on clonal dynamics and on antibiotic consumption applying selective pressure. Among , higher MR rates are found in the viridans group, and , and lower MR rates are described in . When considering different geographic areas, higher resistance rates are usually found in East-Asian countries and milder or lower in the US and Europe. Unfortunately, the availability of data varies also between countries; it is scarce in low- and middle- income countries from Africa and South America. Thus, surveillance studies of macrolide resistance rates and the resistance determinants involved should be promoted to complete global knowledge among macrolide resistance dynamics.

Citing Articles

In Silico Identification of Potential Clovibactin-like Antibiotics Binding to Unique Cell Wall Precursors in Diverse Gram-Positive Bacterial Strains.

Sierra-Hernandez O, Saurith-Coronell O, Rodriguez-Macias J, Marquez E, Mora J, Paz J Int J Mol Sci. 2025; 26(4).

PMID: 40004190 PMC: 11855776. DOI: 10.3390/ijms26041724.

Regulation of erm(T) MLS phenotype expression in the emergent emm92 type group A Streptococcus.

Powell L, Choi S, Grund M, Demkowicz R, Berisio R, LaSala P NPJ Antimicrob Resist. 2025; 2(1):44.

PMID: 39843607 PMC: 11721399. DOI: 10.1038/s44259-024-00062-3.

Fusion Partner Facilitates Expression of Cell-Penetrating Peptide L2 in .

Li X, Yang N, Fang Y, Mao R, Hao Y, Teng D Antibiotics (Basel). 2025; 13(12.

PMID: 39766597 PMC: 11672777. DOI: 10.3390/antibiotics13121207.

Prediction of antimicrobial susceptibility of pneumococci based on whole-genome sequencing data: a direct comparison of two genomic tools to conventional antimicrobial susceptibility testing.

Sanchez G, Cuypers L, Laenen L, Majek P, Lagrou K, Desmet S J Clin Microbiol. 2025; 63(2):e0107924.

PMID: 39745445 PMC: 11837510. DOI: 10.1128/jcm.01079-24.

Treatment of acute pharyngitis in children: an Italian intersociety consensus (SIPPS-SIP-SITIP-FIMP-SIAIP-SIMRI-FIMMG).

Chiappini E, Simeone G, Bergamini M, Pellegrino R, Guarino A, Staiano A Ital J Pediatr. 2024; 50(1):235.

PMID: 39501298 PMC: 11539554. DOI: 10.1186/s13052-024-01789-5.

References

Gonzalez-Diaz A, Camara J, Ercibengoa M, Cercenado E, Larrosa N, Quesada M . Emerging non-13-valent pneumococcal conjugate vaccine (PCV13) serotypes causing adult invasive pneumococcal disease in the late-PCV13 period in Spain. Clin Microbiol Infect. 2019; 26(6):753-759. DOI: 10.1016/j.cmi.2019.10.034. View

Bowers J, Driebe E, Nibecker J, Wojack B, Sarovich D, Wong A . Dominance of multidrug resistant CC271 clones in macrolide-resistant streptococcus pneumoniae in Arizona. BMC Microbiol. 2012; 12:12. PMC: 3285076. DOI: 10.1186/1471-2180-12-12. View

Ardanuy C, Domenech A, Rolo D, Calatayud L, Tubau F, Ayats J . Molecular characterization of macrolide- and multidrug-resistant Streptococcus pyogenes isolated from adult patients in Barcelona, Spain (1993-2008). J Antimicrob Chemother. 2010; 65(4):634-43. DOI: 10.1093/jac/dkq006. View

Okade H, Funatsu T, Eto M, Furuya Y, Mizunaga S, Nomura N . Impact of the pneumococcal conjugate vaccine on serotype distribution and susceptibility trends of pediatric non-invasive Streptococcus pneumoniae isolates in Tokai, Japan over a 5-year period. J Infect Chemother. 2014; 20(7):423-8. DOI: 10.1016/j.jiac.2014.03.010. View

Villasenor-Sierra A, Katahira E, Jaramillo-Valdivia A, Barajas-Garcia M, Bryant A, Morfin-Otero R . Phenotypes and genotypes of erythromycin-resistant Streptococcus pyogenes strains isolated from invasive and non-invasive infections from Mexico and the USA during 1999-2010. Int J Infect Dis. 2012; 16(3):e178-81. PMC: 3288751. DOI: 10.1016/j.ijid.2011.11.005. View

Rafei R, Hawli M, Osman M, Dabboussi F, Hamze M . Distribution of emm types and macrolide resistance determinants among group A streptococci in the Middle East and North Africa region. J Glob Antimicrob Resist. 2020; 22:334-348. DOI: 10.1016/j.jgar.2020.02.005. View

Montes M, Tamayo E, Mojica C, Garcia-Arenzana J, Esnal O, Perez-Trallero E . What causes decreased erythromycin resistance in Streptococcus pyogenes? Dynamics of four clones in a southern European region from 2005 to 2012. J Antimicrob Chemother. 2014; 69(6):1474-82. DOI: 10.1093/jac/dku039. View

Lonks J, Garau J, Gomez L, Xercavins M, Ochoa de Echaguen A, Gareen I . Failure of macrolide antibiotic treatment in patients with bacteremia due to erythromycin-resistant Streptococcus pneumoniae. Clin Infect Dis. 2002; 35(5):556-64. DOI: 10.1086/341978. View

Haenni M, Lupo A, Madec J . Antimicrobial Resistance in spp. Microbiol Spectr. 2018; 6(2). PMC: 11633561. DOI: 10.1128/microbiolspec.ARBA-0008-2017. View

10.

Zintgraff J, Gagetti P, Napoli D, Sanchez Eluchans N, Irazu L, Moscoloni M . Invasive Streptococcus pneumoniae isolates from pediatric population in Argentina for the period 2006-2019. Temporal progression of serotypes distribution and antibiotic resistance. Vaccine. 2021; 40(3):459-470. DOI: 10.1016/j.vaccine.2021.12.008. View

11.

Van Boeckel T, Gandra S, Ashok A, Caudron Q, Grenfell B, Levin S . Global antibiotic consumption 2000 to 2010: an analysis of national pharmaceutical sales data. Lancet Infect Dis. 2014; 14(8):742-750. DOI: 10.1016/S1473-3099(14)70780-7. View

12.

Calle-Miguel L, Perez-Mendez C, Miguel-Martinez M, Lombrana-Alvarez E, Garcia-Garcia E, Solis-Sanchez G . [Resistance rates and phenotypic characterization of Streptococcus pyogenes in a paediatric population in Northern Spain (2005-2015)]. Rev Esp Quimioter. 2017; 30(2):90-95. View

13.

Toda H, Satoh K, Komatsu M, Fukuda S, Nakamura T, Jikimoto T . Laboratory surveillance of antimicrobial resistance and multidrug resistance among Streptococcus pneumoniae isolated in the Kinki region of Japan, 2001-2015. J Infect Chemother. 2018; 24(3):171-176. DOI: 10.1016/j.jiac.2017.12.010. View

14.

Morici E, Simoni S, Brenciani A, Giovanetti E, Varaldo P, Mingoia M . A new mosaic integrative and conjugative element from Streptococcus agalactiae carrying resistance genes for chloramphenicol (catQ) and macrolides [mef(I) and erm(TR)]. J Antimicrob Chemother. 2016; 72(1):64-67. DOI: 10.1093/jac/dkw367. View

15.

Sirekbasan L, Gonullu N, Sirekbasan S, Kuskucu M, Midilli K . Phenotypes and genotypes of macrolide-resistant streptococcus pneumoniae. Balkan Med J. 2015; 32(1):84-8. PMC: 4342144. DOI: 10.5152/balkanmedj.2015.15169. View

16.

Benbachir M, Elmdaghri N, Belabbes H, Haddioui G, Benzaid H, Zaki B . Eleven-year surveillance of antibiotic resistance in Streptococcus pneumoniae in Casablanca (Morocco). Microb Drug Resist. 2012; 18(2):157-60. DOI: 10.1089/mdr.2011.0130. View

17.

Guo D, Cao X, Li S, Ou Q, Lin D, Yao Z . Neonatal colonization of group B Streptococcus in China: Prevalence, antimicrobial resistance, serotypes, and molecular characterization. Am J Infect Control. 2018; 46(3):e19-e24. DOI: 10.1016/j.ajic.2017.10.020. View

18.

Raddaoui A, Simoes A, Baaboura R, Felix S, Achour W, Othman T . Serotype Distribution, Antibiotic Resistance and Clonality of Streptococcus pneumoniae Isolated from Immunocompromised Patients in Tunisia. PLoS One. 2015; 10(10):e0140390. PMC: 4604151. DOI: 10.1371/journal.pone.0140390. View

19.

Zheng P, Chan Y, Chiou C, Hsieh C, Chiang-Ni C, Wu J . Highly prevalent emmSTG840.0 and emmSTC839.0 types of erythromycin non-susceptible group G Streptococcus isolated from bacteremia in southern Taiwan. J Microbiol Immunol Infect. 2017; 50(6):831-838. DOI: 10.1016/j.jmii.2016.12.010. View

20.

Villalon P, Saez-Nieto J, Rubio-Lopez V, Medina-Pascual M, Garrido N, Carrasco G . Invasive Streptococcus pyogenes disease in Spain: a microbiological and epidemiological study covering the period 2007-2019. Eur J Clin Microbiol Infect Dis. 2021; 40(11):2295-2303. DOI: 10.1007/s10096-021-04279-2. View